Showing results (941-950 of 1,007) with videos related to

Sort By:
Pageof 101
Blood Advances|March 5, 2026
Validation of ICC hierarchical classification in secondary AMLEnrico Attardi, Marta Cipriani, Luca Guarnera, et al.
BMC Cancer|December 3, 2021
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)Nieves Martinez Chanza, Louisa Soukane, Philippe Barthelemy, et al.
Targeted Oncology|November 19, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation TrialCéleste Lebbé, Antoine Italiano, Nadine Houédé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2017
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced MalignanciesPhilippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Frontiers in Immunology|November 23, 2017
Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast CancerCinzia Solinas, Soizic Garaud, Pushpamali De Silva, et al.
Journal for Immunotherapy of Cancer|June 25, 2021
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trialJohnny Duerinck, Julia Katharina Schwarze, Gil Awada, et al.
JCI Insight|July 8, 2021
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Sanghee Hong, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid TumorsJames Spicer, Aurélien Marabelle, Jean-Francois Baurain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 studyA Psyrri, C Fortpied, G Koutsodontis, et al.
Pageof 101